Menu

Experience

Eric Blanchard

    • Cerevel Therapeutics – $253.8 Million Follow-on Offering and Concurrent $345.0 Million Rule 144A Convertible Notes Offering 


    • Verona Pharma – $150 Million Follow-on Offering 


    • The Clorox Company – $1.1 Billion Unsecured Senior Notes Offering 


    • Xometry – $287 Million Convertible Senior Notes Offering 


    • SOPHiA Genetics – $234 Million IPO 


    • Xometry – $348 Million IPO 


    • GH Research – $184 Million IPO 


    • Immunocore $312.1 Million Aggregate Financing 


    • SPAC BowX Agrees to $9 Billion Merger With WeWork 


    • Olink Holding – $406 Million IPO 


    • Kadmon Holdings – $240 Million Convertible Notes Offering 


    • Immunocore – $297 Million IPO 


    • Landos Biopharma – $100 Million IPO 


    • Pharming Group – Direct Listing 


    • 908 Devices – $150 Million IPO